Evidence map›Paper›PMID 24921973›Full record

ArticleAmerican journal of respiratory cell and molecular biology2014

Role of C-C motif ligand 2 and C-C motif receptor 2 in murine pulmonary graft-versus-host disease after lipopolysaccharide inhalations.

Tereza Martinu, Kymberly M Gowdy, Julia L Nugent, Jesse Sun, Christine V Kinnier, Margaret E Nelson, Matthew A Lyes, Francine L Kelly, W Michael Foster, Michael D Gunn and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Tereza Martinu1 Department of Medicine and.
Kymberly M Gowdy
Julia L Nugent
Jesse Sun
Christine V Kinnier
Margaret E Nelson
Matthew A Lyes
Francine L Kelly
W Michael Foster
Michael D Gunn
Scott M Palmer
University of North Carolina at Chapel Hill · USClinical Research Institute · USMassachusetts General Hospital · USNational Institute of Environmental Health Sciences · US

Funding

MATRIX REGULATION OF FIBROPROLIFERATIVE LUNG DISEASEP50HL084917 · NHLBI · DUKE UNIVERSITY · PI WRIGHT, JO RAE · 2006 to 2010
$13.2M
Genetic Regulation of Lung Transplant OutcomesK24HL091140 · NHLBI · DUKE UNIVERSITY · PI PALMER, SCOTT M · 2008 to 2012
$712k
NCRR FACSARIA CELL SORTER: LUNGS10RR019145 · NCRR · DUKE UNIVERSITY · PI HAYNES, BARTON F · 2004 to 2004
$435k
NCRR NIH HHS S10 RR019145NCRR NIH HHS S10RR019145NHLBI NIH HHS 1 K24 HL91140-01A2NHLBI NIH HHS 1P50-HL084917-01NHLBI NIH HHS K24 HL091140NHLBI NIH HHS P50 HL084917
6 · The paper itself

Abstract

Environmental exposures are a potential trigger of chronic pulmonary graft-versus-host disease (pGVHD) after successful recovery from hematopoietic cell transplant (HCT). We hypothesized that inhalations of LPS, a prototypic environmental stimulus, trigger pGVHD via increased pulmonary recruitment of donor-derived antigen-presenting cells (APCs) through the C-C motif ligand 2 (CCL2)-C-C motif receptor 2 (CCR2) chemokine axis. B10.BR(H2(k)) and C57BL/6(H2(b)) mice underwent allogeneic (Allo) or syngeneic (Syn) HCT with wild-type (WT) C57BL/6, CCL2(-/-), or CCR2(-/-) donors. After 4 weeks, recipient mice received daily inhaled LPS for 5 days and were killed at multiple time points. Allo mice exposed to repeated inhaled LPS developed prominent lymphocytic bronchiolitis, similar to human pGVHD. The increase in pulmonary T cells in Allo mice after LPS exposures was accompanied by increased CCL2, CCR2, and Type-1 T-helper cytokines as well as by monocytes and monocyte-derived dendritic cells (moDCs) compared with Syn and nontransplanted controls. Using CCL2(-/-) donors leads to a significant decrease in lung DCs but to only mildly reduced CD4 T cells. Using CCR2(-/-) donors significantly reduces lung DCs and moDCs but does not change T cells. CCL2 or CCR2 deficiency does not alter pGVHD pathology but increases airway hyperreactivity and IL-5 or IL-13 cytokines. Our results show that hematopoietic donor-derived CCL2 and CCR2 regulate recruitment of APCs to the Allo lung after LPS exposure. Although they do not alter pathologic pGVHD, their absence is associated with increased airway hyperreactivity and IL-5 and IL-13 cytokines. These results suggest that the APC changes that result from CCL2-CCR2 blockade may have unexpected effects on T cell differentiation and physiologic outcomes in HCT.

Indexed as

AnimalsCell DifferentiationCells, CulturedChemokine CCL2Coculture TechniquesDendritic CellsGraft vs Host DiseaseHematopoietic Stem CellsHematopoietic Stem Cell TransplantationInterleukin-5LipopolysaccharidesLungMaleMice, Inbred C57BLReceptors, CCR2T-LymphocytesCcl2 protein, mouseCcr2 protein, mouseChemokine CCL2Interleukin-5LipopolysaccharidesReceptors, CCR2C-C motif ligand 2C-C motif receptor 2dendritic cellsgraft-versus-host diseaselipopolysaccharide

Identifiers

PMID24921973
PMCPMC4291544
OpenAlexW2099268521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.